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CHAPTER 2.4
Acetylcholine: II. Nicotinic Receptors
Joyce Besheer and Rick A. Bevins 
Abstract
The nicotinic cholinergic system has been widely implicated in mediating learning and/or memory pro-
cesses in human and nonhuman animals. This chapter highlights various areas of basic research in which 
stimulation or blockade of nicotinic  acetylcholine receptors (nAChRs) has been shown to affect an ani-
mals performance in a variety of tasks thought to measure learning and memory. For example, under cer-
tain conditions, stimulation of nAChRs by nicotine (or other nAChRs agonists) can enhance working 
memory of primates as measured in a delayed matching-to-sample task. Attentional processes are also 
improved in rats as indexed by a fi ve-choice serial reaction time task. Further, recent research suggests 
that stimulation of nAChRs by nicotine likely enhances the incentive salience of stimuli. We elabo rate on 
a model by which this enhancement might occur and suggest that the role of this incentive mechanism in 
relation to learning and memory processes requires more empirical attention. Finally, there appears to be 
overlap in the processes by which nAChRs affect learning and memory. That is, enhanced incentive sa-
lience might be responsible for the increased attentional  effects of nicotine, or vice versa. Subsequent re-
search needs to refi ne the behavioral techniques so as better dissociate, if required, these mechanisms.
Introduction
A survey of the neuropharmacology literature would likely leave even the most critical indi vidual con-
vinced that nicotinic  acetylcholine receptors (nAChRs) are involved in learning and/ or memory process-
es in human and nonhuman animals. For example, in humans nAChRs have been implicated in memory 
and learning diffi culties displayed by patients suffering from Alzheimer’s disease66 and attention defi -
cit disorder.58 In rodent and nonhuman primate mod els, manipulation of nAChRs can alter performance 
in such learning tasks as radial-arm maze,49,52,53,65 Morris water maze,1,26   T-maze,6 delayed matching13 
and nonmatching to sample,38 delayed matching-to-position,31 5-choice serial reaction time,11,41,64 envi-
ronmental familiarization,9 passive avoidance,28,74 signal detection,14 latent inhibition,79 “learned help-
lessness”,36  and context conditioning.40 In the past decade or so, there have been several thought-pro-
voking reviews on the role of nAChRs in learning, cognition, and memory.18,56,78 We encourage readers 
interested in this aspect of nicotinic receptor functioning to seek these other reviews because of the vast-
ness of the relevant literature and the differences in emphasis between reviews—including the present 
review.
Neuronal nAChRs
Before any detailed discussion of the functional role of nAChRs in learning and memory processes, it 
may be helpful to provide a brief overview of the main subtypes of neuronal nAChRs and their neuro-
anatomical localization within the central nervous system (CNS). For a comprehensive review of brain 
nAChRs we refer the reader to Changeux et al..18
Published in From Messengers to Molecules: Memories Are Made of These, edited by Gernot Riedel and Bettina Platt. Georgetown, TX 
(Landes Bioscience/Eurekah.com, 2003), pp. 113–124.  Copyright © 2004 Eurekah.com and Kluwer Academic/Plenum Publishers. Used 
by permission.  http://www.landesbioscience.com/ 
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Subtypes
Nicotinic acetylcholine receptors are ligand-gated ion channels. This receptor is composed of fi ve poly-
peptide subunits that form a barrel-like structure around a central ion channel.21 In contrast to nAChRs lo-
cated in the periphery which are composed of α1, β1, δ, ε, γ subunits, the standard confi guration of the neu-
ronal nAChRs include combinations of α and β sub-units. However, α7, α8, and α9 subunits can also form 
functional nAChRs that consist of a single subunit type.25 Presently, the subunits α2–α7 and β2–β4 have 
been identifi ed in the human brain and the distribution of these subunits in the human brain are presently 
being examined (see ref. 71 for a review of the nAChRs in the human brain). As in other receptor systems, 
much more work has examined the distribution of nAChR subunits in the rodent brain. In rodent models, 
the α3, α7, β2 subunits, and to a lesser extent the α4 subunit are expressed in the hippocampus (see ref. 
73). The α2, α4, α5, α7, β2, and β4 subunits have been identifi ed in the interpeduncular nucleus, and ex-
pression of the α3, α4, α7, and β2 subunits have been reported in the amygdala.89 For a more detailed de-
scription of the distribu tion of the various subunits see Arneric et al.2 and Shacka and Robinson.89 Most of 
the neu ronal nAChRs contain α4β2 or α7 subunits37,90,94,99 and these are the subunits that have been most 
commonly studied in learning and memory tasks (see later). Although, this chapter fo cuses on the contri-
bution of central nAChR processes in learning and memory, the role of nAChRs located in the peripheral 
nervous system should not be ignored (see ref. 89 for discus sion of peripheral nAChRs).
Localization
Acetylcholine (ACh) is the endogenous transmitter substance that binds to functional nAChRs. Much 
of the research localizing these ACh-utilizing (cholinergic) neurons in the central nervous system has 
employed immunohistochemistry staining for choline acetyltransferase (ChAT); an enzyme required 
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for synthesis of ACh. Table 1 provides a summary of the CNS localization of major clusters of 
ChAT-containing neurons in mam mals. Also, included in (Table 1) are some of the notable brain re-
gions that receive projec tions from these cholinergic cells. The “Ch” nomenclature allows for sim-
pler designation of diffuse collections of cholinergic neurons.62,95 For example, Ch3 is located in the 
basal forebrain and includes neurons in the horizontal limb nucleus of the diagonal band and mag-
nocellular preoptic area of the hypothalamus. We will reference back to this table when discuss-
ing the functional importance of nAChRs. For example, cholinergic input from Chl may affect 
learning by modulating α7* nAChRs in the hippocampus (see later). Because a comprehensive re-
view of the cholinergic system is tangential to our goal, we refer the reader to the following reports 
for a more detailed discussion of the cholinergic system: Mesulam (refs. 62,63) and Woolf (ref. 98).
Memory
Manipulation of nAChRs has been shown to affect performance in a variety of tasks that assess memo-
ry functioning. In nonhuman animals, a majority of this work has been conducted in tasks designed to as-
sess working memory processes. Working memory is defi ned by Feldman et al..34 as “encoding of task-
specifi c information over short periods of time (e.g., within a single trial or test session)” (p. 272). The 
delayed matching-to-sample (DMTS) task is a commonly used preparation for assessing working mem-
ory. Briefl y, in this task an animal is presented with a “sample” stimulus. Following a delay, the animal 
is presented with the sample stimulus and one or more novel stimuli. During this choice test, the animal 
is rewarded for choosing the sample stimulus. Thus, working memory processes are recruited to encode 
the information of the sample stimulus in order to make a correct response during the choice test. That is, 
working memory allows the animal to discriminate between the sample stimulus and the other stimuli.
The DMTS task has been widely used to examine the role of nAChRs. For example, Buccafusco et 
al..13 trained mature pig-tailed and rhesus monkeys on the DMTS task using colored lights as the stimuli. 
After acquisition training, the monkeys were tested at 4 different delays: zero, short, medium, and long. 
At the zero delay, the choice test occurred immediately following the presentation of the sample stimu-
lus. The other delays were adjusted for each monkey’s skill level; on average the short delay was 10.6 
sec, the medium delay 39.4 sec, and the long delay 79.4 sec. Presumably, lengthening the delay impairs 
performance in this task because of the limited capacity of working memory processes.31 Indeed, perfor-
mance ranged from 97% correct after the zero delay to 58% correct after the long delay. In order to as-
sess if stimulation of the nicotinic receptors could enhance working memory performance, the ani mals 
were administered ABT-418, a nAChR agonist (i.e., cholinergic channel activator). ABT-418 did not af-
fect performance at the zero, short, or medium delays. However, at the long delay, DMTS performance 
was enhanced by treatment with ABT-418. After a washout period, all animals were tested with nicotine, 
an agonist at nAChRs with a high affi nity for α4β2*.20 Similar to ABT-418, nicotine enhanced perfor-
mance only at the longest delay.
The inability of nAChR agonists to improve performance in the DMTS task at the shorter delays like-
ly indicates that performance was near optimal levels at the shorter delays, thus making an improvement 
diffi cult to observe. However, improvement at the long delay suggests that stimulation of the nAChRs af-
fected memory processes when strained. Recall that at the long delay performance was impaired (58% 
correct versus 97% correct after no delay). As mentioned earlier, impaired performance in this task af-
ter long delays is taken to suggest a disturbance in the capacity of working memory.31 Thus, one possi-
bility for the enhancement in performance is that the agonists stimulated working memory processes by 
enhancing the capacity to store the information of the sample stimuli. Given that a major component of 
working memory tasks involve attention,12 another tenable and related possibility, is that attentional pro-
cesses were enhanced such that the neural representation of the sample stimulus was stored/encoded more 
effi ciently. Indeed, stimulation of nAChRs has been shown to en hance attentional processes (see later).
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Further, there is a wealth of research examining the role of nAChRs in mediating perfor mance in oth-
er tasks that include a working memory component. For example. Levin et al. .53-55 has repeatedly found 
that chronic nicotine treatment enhances performance in a win-shift version of a radial arm maze. In this 
particular version of the task, the arms of the maze are baited and entries into arms that had been previ-
ously visited are scored as errors. The number of errors is taken as a measure of working memory func-
tion given that the rat must encode the information about the location of visited arms. Similar to chron-
ic nicotine, AR-R17779, an agonist for the α7 subunit, enhances performance in this task.57 Further, Felix 
and Levin35 found that methyllycaconitine (MLA), an antagonist specifi c for the α7 subunit, or dihydro-
β-erythroidine (DHBE), an antagonist with affi nity for the α4β2* nAChR, infused into the ventral hippo-
campus impaired performance in the win-shift version of the radial-arm maze. This impairment suggests 
a role for hippocampal α4β2* and α7* nAChRs in working memory processes.
Interestingly, the greatest performance improvements resulting from stimulation of nAChRs are common-
ly reported in tasks that require effortful processing38,84 or in tasks in which a defi cit is produced.29,56 For 
example, in the DMTS task described earlier, enhanced perfor mance was not observed until the delay in-
duced a severe defi cit in performance. Similar fi nd ings have been reported using a novel-object detection 
task (also referred to as object recogni tion). In that task, a rat is presented with two identical sample objects. 
After a delay, the rat is presented with a novel object and one of the previously experienced objects. Rats 
display a tendency to interact more with the novel object than the familiar object when the delay is 1 h (i.e., 
delayed nonmatching-to-sample; see refs. 7 and 33). However, Puma et al..77 found that after a 24 h delay 
rats did not discriminate between the objects (i.e., equal time with the novel and familiar object). Admin-
istration of nicotine after exposure to the sample objects reversed this “defi cit;” rats spent more time inter-
acting with the novel object during the test that oc curred 24 h later. Presumably, stimulation of the nAChRs 
enhanced the retention (consolida tion) of the information about the sample objects during the long delay.77 
Nicotine has also been reported to enhance retention in a passive avoidance task.74 Interestingly, in that 
study, mice lacking the β2 subunit of the nAChR did not show the nicotine-induced enhancement in reten-
tion, suggesting a role for this subunit in retention processes (e.g., consolidation, encoding, etc.).
Defi cits in performance induced by lesions have also been reversed by nAChR stimulation. For exam-
ple. Decker et al..29 found that lesions of the septal area, which reduced cholinergic input to the hippo-
campus (see Table 1), induced an impairment in a spatial discrimination version of a Morris water maze 
task. Administration of ABT-418 reversed the lesion-induced defi cit, but had no effect on intact controls. 
Interestingly, this drug was subsequently tested by Potter et al..76 in patients with early to moderate Al-
zheimer’s Disease, a disease which is accom panied by memory impairments and degeneration of the cho-
linergic system. ABT-418 treated patients tested on the Selective Reminding Task had improved recall 
across a 6 h testing period.
Interestingly, stimulation of nAChRs does not appear to affect performance in tasks that involve reference 
memory (i.e., use of the same information across trials).12 For example, ad ministration ofSIB-1553A, a β4* 
nAChR agonist, did not affect performance in mice that were trained to discriminate between a baited and 
unbaked arm of a T-maze.12 Similarly, Levin et al..55 found that chronic nicotine treatment did not affect 
performance in a 16-arm radial maze in which specifi c arms were repeatedly unbaked. Further, Granon et 
al..38 reported that antagonism of nAChR by administration of neuronal bungarotoxin (NBT) did not affect 
per formance in a reference memory component of a T-maze task; NBT, however, impaired work ing memo-
ry. Notably, mecamylamine, a noncompetitive nAChR antagonist, infused into the hippocampus did not af-
fect reference memory, but impaired working memory.67 This result suggests that nAChRs in the hippocam-
pus are involved in mediating working memory, but not reference memory processes.
There clearly exists a wealth of research examining the role of nAChRs in mediating perfor mance in 
a variety of tasks. Stimulation of nAChRs generally appear to enhance performance in working memory 
tasks and tasks that involve retention of information across a delay. Further, nAChR processes in work-
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ing memory and retention (consolidation) mechanisms appear to be especially important in restoring 
performance induced by degeneration of the cholinergic system, whether the defi cit is naturally oc-
curring (i.e., aging) or induced by a lesion. From our reading of the literature, an important factor that 
may contribute to this restoration includes alterations in attentional processes mediated by nAChRs 
(see following section). Presumably, increasing attention to specifi c stimuli would result in better en-
coding of the information. In turn, this information would be neurally retained more effectively and be 
more readily avail able for future use. Further, in a later section (Rewarding/Incentive Effects), we pro-
pose an other mechanism that may contribute to the enhanced performance observed with nicotinic re-
ceptor stimulation.
Attention
The cholinergic system has been implicated in mediating attentional processes in humans and nonhu-
man animals.11,50,59,64,85,96 For example, in human studies, smoking a cigarette (e.g., nicotine adminis-
tration) before presentation of a word list improved the number of words correctly recalled during a later 
test.83,96 Specifi cally, Warburton et al.. found that more words from the latter part of the list were re-
called; this pattern was consistent with an attentional explanation to the extent that attention diminishes 
towards the latter part of the list. Similarly, Rusted and Eaton-Williams83 found that nicotine-induced ac-
curacy improvements in word recall was related to the length of the word list. That is, a greater improve-
ment was observed after presentation of a 30-item word list, than a 10-item word list. Nicotine delivered 
by a transdermal patch has also been shown to enhance performance in a Random Letter Genera tion task 
(e.g., participants required to name letters of the alphabet in a random order) and a Stroop test (e.g., par-
ticipants required to read the ink color of color words), presumably by enhancing attentional processes.59
Nonhuman animal studies have also focused on nAChR involvement in attentional pro cesses. The 
fi ve-choice serial reaction time (5-CSRT) task has been used in rodents to assess the role of various 
nicotinic agonists and antagonists in attentional processes. Commonly, the ap paratus used for this task 
includes a wall with fi ve distinct holes, each with a light at the rear of the hole. During training, one of 
the fi ve holes is illuminated for a brief duration. A correct response is registered for nose pokes during 
the period that the light is illuminated or for a fi xed interval after the offset of the light. Daily training 
sessions usually include about 100 trials (i.e., random light illuminations). Thus, accurate performance 
in this task involves sustained atten tion and vigilance throughout the entire session.
Mirza and Stolerman64 found that increasing the time between each light presentation re sulted in 
a performance decrement, likely because prolonged vigilance was necessary to main tain correct re-
sponding. Nicotine administration reversed this defi cit suggesting that attentional processes were en-
hanced. Interestingly, shortening the duration of the stimulus illumination (i.e., weakening the signal 
strength), decreased correct responding, and increased the latency to make a response.11 According to 
the authors, this data pattern indicates that information pro cessing, not necessarily attentional process-
ing, is impaired. Under these conditions, nicotine administration did not enhance correct responding. 
Together these results suggest that stimu lation of nAChRs by nicotine can enhance attentional process-
es, but may not necessarily affect informational processing (see ref. 92 for a review of the effects of 
nicotine in the 5-CSRT task). Further, using the short duration light stimulus, Blondel et al.11 replicat-
ed the fi ndings of Mirza and Stolerman64 in that nicotine administration did not affect the number of 
correct responses. However, the authors did fi nd that nicotine decreased the latency to make a correct 
response and increased anticipatory responses.
To further assess the role of the specifi c subunits of the nicotinic receptor that may contrib ute to atten-
tional processes, Grottick and Higgins41 assessed various compounds in rats that had failed to meet crite-
rion during 5-CSRT task training. Presumably, attentional/vigilance processes in these rats were slightly 
impaired given that they had failed to meet the predeter mined criterion. Rats were administered nicotine, 
AR-R 17779 (an α7* agonist), or SIB 1765F (an α4β2* agonist). Both nicotine and SIB 1765F improved 
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performance by increasing correct responding and enhancing reaction time. In contrast, AR-R 17779 did 
not affect correct re sponding. This data pattern was taken to suggest involvement of the α4β2, but not the 
α7 subunits, in mediating increased attention/vigilance. Additionally, SIB-1553A, a β4* nAChR agonist, 
had no effect on correct responding in the 5-CSRT task in aged rats, whereas perfor mance in aged rats 
was enhanced by nicotine administration.43 Taken together this work sug gests that the β4* nAChR is not 
involved in attentional processes as measured in a 5-CSRT task.
In sum, performance on tasks designed to measure attention processes can be enhanced by stimula-
tion of nicotinic receptors. Specifi cally, the α4 and β2 subunits appear to contribute to this enhancing ef-
fect. Notably, researchers have begun to examine the feasibility of using nAChR compounds as potential 
therapeutic agents for attention defi cit/hyperactivity disorder (ADHD). Nicotine delivered by a transder-
mal patch to adults with ADHD showed some effect in aiding attentional processes;58 however, further 
research in this area is required.
Rewarding/Incentive Effects
The nAChR agonist nicotine acts on dopaminergic pathways (see Fig. 1) implicated in the rewarding 
or the incentive-motivational effects of stimuli such as food, play, or copulatory opportunity.70,88 Notably, 
nicotines action in this “incentive/approach system” and the condi tioned effect associated with this action 
is used to explain the acquisition and maintenance of compulsive tobacco use,44,45,80 and the over 95% 
relapse rate following abstinence without pharmacotherapy.16,17     Animal models such as self-adminis-
tration and intracranial self-stimulation have been employed to elucidate the behavioral and neurobiolog-
ical processes underlying these effects of nicotine.15,46,69,81 For example, rodents and nonhuman primates 
prepared with an intravenous catheter will press more on a lever that produces contiguous intravenous de-
livery of nicotine. The differential increase in responding (self-administration) maintained by nicotine re-
quires normal functioning of the system outline in Figure 1. For example, nicotine self-administration in 
rats is decreased with bilateral 6-hydroxydopamine lesions of the dopaminergic projections between the 
ventral tegmental area (VTA) and nucleus accumbens,23 or by infusions of a nAChR antagonist, DHβE, 
into the VTA.24 Further, selec tive cholinergic lesioning of the pedunculopontine tegmental nucleus, a ma-
jor cholinergic projection to the VTA, also attenuates nicotine self-administration.51 Finally, mice lacking 
the β2 subunit fail to self-administer nicotine.32
Additional empirical work has implicated nAChRs located on the cell bodies in the VTA and on the 
terminals of glutamatergic projections from the prefrontal cortex to the VTA.27,47,60 These excitatory glu-
tamatergic projections stimulate VTA neurons resulting in dopamine re lease.48 Theorists have suggest-
ed that this release of dopamine, especially in the nucleus accumbens, is important for various aspects of 
the rewarding/incentive effects of appetitive stimuli and the conditioned approach effects engendered by 
these stimuli (de Bruin, this book and refs. 3,10,27). Dopamine release in the nucleus accumbens is in-
creased in vitro and in vivo with nicotine. This prolonged increase in dopamine release appears to be me-
diated by long-term potentiation of VTA cells containing NMDA receptors—a glutamate receptor se-
lective for the agonist N-methyl-D-aspartate.87 The α7* nAChRs located on the presynaptic terminals 
of projections from the prefrontal cortex are important for inducing this long-term potentiation in the 
VTA.60,88 The α4β2* nAChR located on the cell bodies of VTA neurons quickly desen sitize to the pres-
ence of nicotine and are unlikely to contribute to the long-term enhancement of dopamine release.27,75
Although there is a massive empirical literature studying the functional effects of dopamine release in 
this system, there is still disagreement as to its role in incentive-related behaviors. The following quote 
by Dani et al..27 provides a good summary that is consistent with our thinking and will serve as basis for 
suggesting a broad role of the nAChR-mediated neural plasticity of this system in learning and memory.
“DA [dopamine] concentrations in the NAc [nucleus accumbens] are not a scalar indica tion of re-
ward. More likely, the DA signal conveys novelty and reward expectation or serves to indicate the
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Figure 1. Diagram of the main pathways involved in nicotinic acetylcholine synaptic plasticity of the incentive-
motivational (reward) system.
deviation of the environmental input from the animal’s expectations, which were constructed by 
experience. Thus, DA may participate in the ongoing associative learning of adap tive behaviors as 
an animal continually updates a construct of environmental salience” (p. 350).
This conceptualization suggests that the dopamine signal that is enhanced by nicotine’s action on pre-
synaptic terminals containing α7* nAChRs plays a role in neurally attributing incentive salience to the 
stimulus input from a continually changing environment. This neural attribution likely occurs through as-
sociative learning processes, broadly defi ned.3
Recent research by Caggiula and colleagues15 provides an important behavioral example of this pro-
cess. Briefl y, rats were trained to self-administer nicotine such that when the response requirement was 
completed a 1-sec intravenous infusion of nicotine (0.03 mg/kg) was deliv ered; a 1-sec light co-occurred 
with the nicotine infusion. Upon establishing stable self-administration behavior, some rats were switched 
to an extinction phase in which saline replaced nicotine, but the 1-sec cue light still occurred. Although 
lever press rates decreased with the removal of nicotine, the nicotine-associated light still maintained re-
sponding well above controls receiving saline without the cue light. In a separate set of rats, the response-
contingent nicotine infusion continued during the extinction phase, but the light signal was removed. 
Rates of nicotine self-administration also decreased in this group. Notably, the level of responding main-
tained by nicotine alone was comparable to that maintained by the cue light alone. This result is intrigu-
ing if one considers that the rate of behavior maintained by what is conceptualized as the primary rein-
forcer, nicotine, is similar to that controlled by a cue associated with the effects of nicotine. Caggiula et 
al.15 concluded that, “nicotine promotes the establishment or magnifi es the salience of conditioned rein-
forcers” (p. 526). We suggest that a plausible mechanism for this enhanced incentive salience is the ac-
tion of nicotine on the α7* nAChRs located on glutamatergic presynaptic terminals of projections from 
the prefrontal cortex to the VTA. Of course, this proposal requires empirical attention.
Regardless of the specifi c neurobiological processes responsible for enhancing the incentive salience 
of stimuli, this enhancement provides an additional mechanism by which nAChR compounds may broad-
ly affect learning and memory. For example, enhanced attention and/or vigilance (see earlier) may be, 
at least in part, the result of this process. Stimulus events that occur in the presence of nicotine (or oth-
er appropriately selective nAChR agonists) may ac quire, or have potentiated, some appetitive property. 
Presumably this enhanced appetitive quality increases salience and may even require deeper processing 
given the acquired associations. In deed, animals in a free-choice situation spend more time in a distinct 
environment that has been previously paired with appetitive stimuli.4
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Enhanced/magnifi ed incentive salience of cues may also play a role in die improved acqui sition of new 
tasks observed with some nAChR agonists. For example, we found that acquisi tion of a T-maze visual 
discrimination task was faster in chronic nicotine-treated rats than in saline-treated rats.6 Perhaps nicotine 
potentiated the incentive effects of the food used to rein force correct arm choice (i.e., black arm). Accord-
ing to this formulation the incentive salience of the black arm may also be enhanced. That is, any con-
ditioned reinforcing value acquired by the black-arm stimuli repeatedly associated with food may be in-
creased by nicotine. Further, these conditioned effects may be stronger because the appetitive effects of 
food would also be enhanced (see earlier). Finally, the black-arm stimuli may acquire additional incentive 
salience by direct association with nicotine. The cumulative increase in the incentive salience of the stim-
ulus events relevant to learning the discrimination thus enhanced acquisition rates relative to saline con-
trols. Interestingly, reversal learning (white-arm now associated with food) was not altered by nicotine 
pretreatment. Perhaps, the effects of nicotine on the incentive salience re quire the stimulus events to be 
relatively novel (i.e., relatively little learning history). Or, per haps the acquired increase in the incentive 
salience of black arm cues competed with white arm cues that were now becoming associated with food 
and nicotine after a long history on nonreinforcement in a manner similar to nonmagnifi ed cues in the sa-
line controls.
As a fi nal note in this section, we found that enhanced acquisition in the T-maze task was predicted by 
activity in an inescapable novel environment; less reactive rats learned the discrimination faster (see ref. 
6 and Fig. 1). Notably, past research on individual differences pre dicted by reactivity to inescapable nov-
elty has implicated the mesocorticolimbic dopamine system.82,86 The nAChR-mediated long-term po-
tentiation of the VTA increases dopamine release within this system (see Fig. 1) and suggests a poten-
tial process responsible for the pre dictable difference in T-maze learning produced by nicotine. Of course, 
the speculations con cerning incentive salience and the role of nAChR-mediated long-term potentiation in 
learning and memory require further research to provide independent evidence for the processes at a neu-
robiological and behavioral level.
Other Effects
Additional functional effects of nAChRs include alterations in pain, anxiety, appetite, de pression, epi-
lepsy, and motoric abilities. Although a comprehensive discussion of these effects is beyond the scope of 
the present review, their potential infl uence (direct or indirect) on learn ing and memory deserves mention. 
We will use as an example the locomotor effects of centrally located nAChRs. Most of the nonhuman an-
imal research investigating attention, reward, or working memory include controls to assess whether the 
motoric effects of the nAChR ligand of interest could account for group differences. Such controls are 
important in that nAChR agonists can alter general locomotor activity.8,42,61,68,92 Whether the change is 
locomotor suppres sion or stimulation depends on such factors as selectivity of ligand, dose, pretreatment 
or preexposure history, rodent strain, and environmental familiarity. Accordingly, if one is inves tigating 
the memory enhancing effects of, say, chronic nicotine, then an index of locomotor stimulation will be 
important. Arguably, these locomotor stimulant effects could enhance ac quisition and performance in cer-
tain learning tasks perhaps by producing small decreases in the time between stimulus-outcome or behav-
ior-outcome relations (i.e., improved temporal contiguity) inherent in learning situations.72,93,97 Along 
these lines, it is interesting to note that the α4β2* nAChRs42 and increased dopamine release in the nucle-
us accumbens5 appear to be important for the locomotor stimulant effects of nicotine (see section on Re-
ward/Incentive Effects). Likely, future research will begin to more specifi cally identify the links between 
the effects we have listed as “Other” and memory. Perhaps the anxiolytic effects of ABT 41830 or nico-
tine19 allow an animal to use neural processing resources released from this decrease in anxiety toward 
the learning/memory task prescribed by the experimenter.
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Closing Remarks
Advances in molecular biology are clearly refi ning our understanding of the vast structural variation that 
exists in nAChRs. As these advances continue, so will our understanding of nAChR processes in learn-
ing and memory. For example, behavioral geneticists can further develop mutant mice with selective de-
letions of nAChR subunits. Extensive neurobiological and behavioral assessment of these mice will in-
form our theoretical models. Also, continued development of selective ligands will allow researchers to 
dissociate function and receptor sub types. Finally, from our perspective, we need a better understanding of 
the psychological con structs measured by current animal models (e.g., radial arm maze, 5-CSRT) and we 
need fur ther development of new animal models (see Jaffard and Marighetto in this book). Our discussion, 
for example, of the possibility that working memory models may also be measuring attentional processes 
highlights this need. If we do not fully understand what the dependent measures are indexing and the fac-
tors that affect those measures, we will always be unsure of whether the neurobiological process identifi ed 
actually refl ects the psychological construct (memory, learning, attention, reward, etc.) of interest.
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